Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

Over 90% of all cancers are carcinomas, malignancies derived from cells of epithelial origin. As carcinomas progress, these tumors may lose epithelial morphology and acquire mesenchymal characteristics which contribute to metastatic potential. An epithelial-to-mesenchymal transition (EMT) similar to the process critical for embryonic development is thought to be an important mechanism for promoting cancer invasion and metastasis. Epithelial-to-mesenchymal transitions have been induced in vitro by transient or unregulated activation of receptor tyrosine kinase signaling pathways, oncogene signaling and disruption of homotypic cell adhesion. These cellular models attempt to mimic the complexity of human carcinomas which respond to autocrine and paracrine signals from both the tumor and its microenvironment. Activation of the epidermal growth factor receptor (EGFR) has been implicated in the neoplastic transformation of solid tumors and overexpression of EGFR has been shown to correlate with poor survival. Notably, epithelial tumor cells have been shown to be significantly more sensitive to EGFR inhibitors than tumor cells which have undergone an EMT-like transition and acquired mesenchymal characteristics, including non-small cell lung (NSCLC), head and neck (HN), bladder, colorectal, pancreas and breast carcinomas. EGFR blockade has also been shown to inhibit cellular migration, suggesting a role for EGFR inhibitors in the control of metastasis. The interaction between EGFR and the multiple signaling nodes which regulate EMT suggest that the combination of an EGFR inhibitor and other molecular targeted agents may offer a novel approach to controlling metastasis.

• Publication year

  2008

• Venue

  Clinical and Experimental Metastasis

• Publication date

  2008-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10585-007-9121-7PMID 18236164PMCID 2471394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.

  2008cited by this paper
• The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

  2007cited by this paper
• EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Significance of TWIST expression and its association with E-cadherin in bladder cancer.

  2007cited by this paper
• Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway.

  2007cited by this paper
• Expression of snail in pancreatic cancer promotes metastasis and chemoresistance.

  2007cited by this paper
• Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma.

  2007cited by this paper
• Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis.

  2007cited by this paper
• Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma

  2007cited by this paper
• Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

  2007cited by this paper
• Molecular correlates of gefitinib responsiveness in human bladder cancer cells

  2007cited by this paper
• Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis

  2007cited by this paper
• Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.

  2007cited by this paper
• Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients

  2007cited by this paper
• Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

  2007cited by this paper
• Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail

  2007cited by this paper
• Autocrine activation of PDGFRα promotes the progression of ovarian cancer

  2006cited by this paper
• Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.

  2006cited by this paper
• Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

  2006cited by this paper
• Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by αvβ3 integrin signaling

  2006cited by this paper
• Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

  2006cited by this paper
• Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines.

  2006cited by this paper
• Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

  2006cited by this paper
• Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity

  2006cited by this paper
• ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.

  2006cited by this paper
• E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines

  2006cited by this paper
• Autocrine PDGFR signaling promotes mammary cancer metastasis.

  2006cited by this paper
• Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.

  2006cited by this paper
• Fibroblasts in cancer

  2006cited by this paper
• Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells.

  2006cited by this paper
• Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.

  2006cited by this paper
• Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model.

  2006cited by this paper
• Impact of IGF‐1R/EGFR cross‐talks on hepatoma cell sensitivity to gefitinib

  2006cited by this paper
• The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.

  2005cited by this paper
• TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

  2005cited by this paper
• DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

  2005cited by this paper
• Erlotinib in previously treated non-small-cell lung cancer.

  2005influential reference
• Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancer

  2005cited by this paper
• ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.

  2005cited by this paper
• Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells

  2005cited by this paper
• Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.

  2005cited by this paper
• Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes

  2005cited by this paper
• Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression

  2005cited by this paper
• Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma.

  2005cited by this paper
• Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients

  2005cited by this paper
• Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition

  2005cited by this paper
• Snail blocks the cell cycle and confers resistance to cell death.

  2004cited by this paper
• Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.

  2004cited by this paper
• Epidermal Growth Factor Receptor Inhibition Promotes Desmosome Assembly and Strengthens Intercellular Adhesion in Squamous Cell Carcinoma Cells*

  2004cited by this paper
• Effects of Epidermal Growth Factor/Hydrocortisone on the Growth and Differentiation of Human Ovarian Surface Epithelium

  2004cited by this paper
• Signaling through the epidermal growth factor receptor during the development of malignancy.

  2004cited by this paper
• Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.

  2004cited by this paper
• Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors

  2004cited by this paper
• Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004influential reference
• Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma.

  2003cited by this paper
• Epithelial-mesenchymal transitions in development and pathologies.

  2003cited by this paper
• Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

  2003cited by this paper
• Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

  2003cited by this paper
• Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling

  2003cited by this paper
• Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells.

  2003cited by this paper
• Epithelial–mesenchymal transition in breast cancer development

  2003cited by this paper
• Epidermal growth factor receptor dependence in human tumors: more than just expression?

  2002cited by this paper
• Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• The snail superfamily of zinc-finger transcription factors

  2002cited by this paper
• Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.

  2002cited by this paper
• Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo.

  2002cited by this paper
• Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.

  2002cited by this paper
• Snail Induction of Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 Repression andZEB1 Expression*

  2002cited by this paper
• Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex

  2002cited by this paper
• The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.

  2002cited by this paper
• Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

  2001cited by this paper
• Inhibition of Carcinoma Cell Growth and Metastasis by a Vesicular Stomatitis Virus G-Pseudotyped Retrovector Expressing Type I Insulin-Like Growth Factor Receptor Antisense

  2001cited by this paper
• Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer.

  2001cited by this paper
• PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

  2001cited by this paper
• A New Role for E12/E47 in the Repression ofE-cadherin Expression and Epithelial-Mesenchymal Transitions*

  2001cited by this paper
• Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase

  2001cited by this paper
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000cited by this paper
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin.

  2000cited by this paper
• Apoptotic response to TGF-beta in fetal hepatocytes depends upon their state of differentiation.

  1999cited by this paper
• EGF receptor.

  1999cited by this paper
• A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.

  1998cited by this paper
• A causal role for E-cadherin in the transition from adenoma to carcinoma

  1998cited by this paper
• Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors.

  1997cited by this paper
• Tyrosine Phosphorylation of Paxillin and Focal Adhesion Kinase during Insulin-like Growth Factor-I-stimulated Lamellipodial Advance*

  1997cited by this paper
• Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth.

  1996cited by this paper
• Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704.

  1996cited by this paper
• Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor.

  1996cited by this paper
• The Roles of Integrins and Extracellular Matrix Proteins in the Insulin-like Growth Factor I-stimulated Chemotaxis of Human Breast Cancer Cells (*)

  1996cited by this paper
• Mechanisms Identified in the Transcriptional Control of Epithelial Gene Expression (*)

  1996cited by this paper
• Platelet‐derived growth factor in human glioma

  1995cited by this paper
• Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.

  1995cited by this paper
• Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.

  1994cited by this paper
• Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation.

  1994cited by this paper
• Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

  1992cited by this paper

• Role of EMT in drug resistance of breast cancer: molecular mechanisms and therapeutic strategies

  2025cites this paper
• Upregulated bone morphogenetic protein 8A (BMP8A) in triple negative breast cancer (TNBC) and its involvement in the bone metastasis

  2024cites this paper
• An Efficient Suppression of EGFR and B-Raf mRNA Overexpression in the Lung of Benzo[a]pyrene-induced mice by Cationic Lipo-ATRA Nanoformulation.

  2023cites this paper
• Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases

  2023cites this paper
• Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial-mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro.

  2023cites this paper
• The intervention of epithelial-mesenchymal transition in homeostasis of human retinal pigment epithelial cells: a review

  2022cites this paper
• Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study

  2022cites this paper
• High Oxytocin Receptor Expression Linked to Increased Cell Migration and Reduced Survival in Patients with Triple-Negative Breast Cancer

  2022cites this paper
• Synergistic Effect of Curcuma longa Extract in Combination with Phyllanthus niruri Extract in Regulating Annexin A2, Epidermal Growth Factor Receptor, Matrix Metalloproteinases, and Pyruvate Kinase M1/2 Signaling Pathway on Breast Cancer Stem Cell

  2021cites this paper
• Mutant p53 as a Regulator and Target of Autophagy

  2021cites this paper
• Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma

  2021cites this paper
• The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review

  2021cites this paper
• Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway

  2021cites this paper
• Topological data analysis of collective and individual epithelial cells using persistent homology of loops.

  2021cites this paper
• PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT

  2021cites this paper
• Cancer Stem Cells and their Management in Cancer Therapy.

  2020cites this paper
• Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer

  2020cites this paper
• Anticancer Effect of Radix Astragali on Cholangiocarcinoma In Vitro and Its Mechanism via Network Pharmacology

  2020cites this paper
• miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway

  2020cites this paper
• Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas

  2020cites this paper
• Fangchinoline exerts antitumour activity by suppressing the EGFR-PI3K/AKT signalling pathway in colon adenocarcinoma

  2020influential citation
• Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1-AKT/ERK-Snail signaling pathway

  2020cites this paper
• The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells

  2019cites this paper
• mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines.

  2019cites this paper
• Mechanophenotyping of 3D multicellular clusters using displacement arrays of rendered tractions

  2019cites this paper
• Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1

  2019cites this paper
• DNA polymerase iota (Pol ι ) promotes the migration and invasion of breast cancer cell via EGFR-ERK-mediated epithelial to mesenchymal transition

  2019cites this paper
• Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC

  2019cites this paper
• In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM)

  2018cites this paper
• Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis

  2018cites this paper
• The features and prognostic impact of extracranial metastases in patients with epidermal growth factor receptor-mutant lung adenocarcinoma

  2018cites this paper
• Study of the relationship between EGFR mutation status and bone metastasis in advanced lung adenocarcinoma

  2018cites this paper
• PIK3C2B promotes epithelial to mesenchymal transition and EGFR inhibitors insensitivity in epidermal squamous cell carcinoma

  2018cites this paper
• Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis

  2018cites this paper
• Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non‐Small Cell Lung Cancer: The Role of Cancer Stem Cells

  2018cites this paper
• Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review

  2018cites this paper
• Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer

  2017cites this paper
• Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells

  2017cites this paper
• Protein Kinases as Tumor Biomarkers and Therapeutic Targets.

  2017cites this paper
• CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma

  2017cites this paper
• Effect of arenobufagin on human pancreatic carcinoma cells.

  2017cites this paper
• Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer

  2017cites this paper
• Overcoming treatment resistance in cancer: Current understanding and tactics.

  2017cites this paper
• The motogenic effect of EGF and TGF-α on the migration of tumor cells from the oral region

  2017cites this paper
• SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells

  2017cites this paper
• EGFR over-expression and mutations lead to a change in biological characteristics of human lung adenocarcinoma cells

  2017cites this paper
• Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation

  2016cites this paper
• A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?

  2016cites this paper
• IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review).

  2016cites this paper
• IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib

  2016cites this paper
• Ex vivo construction of a novel model of bioengineered bladder mucosa: A preliminary study

  2016cites this paper
• Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer

  2016influential citation
• Cannabinoid receptor‐2 agonist inhibits macrophage induced EMT in non‐small cell lung cancer by downregulation of EGFR pathway

  2016cites this paper
• TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

  2016cites this paper
• EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells

  2016cites this paper
• The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

  2016cites this paper
• Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition

  2016cites this paper
• Potential signaling pathway involved in sphingosine-1-phosphate-induced epithelial-mesenchymal transition in cancer.

  2016cites this paper
• Oral Cancer Biomarkers-as Powerful Diagnostic and Prognostic Tools

  2016cites this paper
• JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma

  2016cites this paper
• Safety Evaluation of GP-EGF Lyophilised Powder

  2016cites this paper
• Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial–Mesenchymal Transition: Effects on Anoikis

  2016cites this paper
• Roles of ADAM12 in triple-negative breast cancer: regulation of cancer stem cells

  2016cites this paper
• Intervention Effect of Ethanol Extract of Hedyotis Diffusa and Gefitinib on the Epithelial Mesenchymal Transition Process of Human Lung Adenocarcinoma Cell H 358 Induced By TGF-β 1

  2016influential citation
• EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation

  2016cites this paper
• Epithelial-mesenchymal Transition is Associated with Acquired Resistance to 5-Fluorocuracil in HT-29 Colon Cancer Cells

  2015cites this paper
• Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells

  2015cites this paper
• Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer.

  2015cites this paper
• XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.

  2015cites this paper
• Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.

  2015cites this paper
• Loss of EGFR expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition

  2015cites this paper
• Intestinal Tumorigenesis

  2015cites this paper
• Epithelial to Mesenchymal Transition (EMT) and Intestinal Tumorigenesis

  2015cites this paper
• Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis

  2015cites this paper
• Avaliação da proliferação e migração celular mediadas pela ativação do EGFR em linhagens celulares de câncer de pulmão cultivadas como monocamadas e esferoides.

  2015cites this paper
• Discovery and validation of podocalyxin-like protein as a prognostic biomarker in colorectal cancer

  2015influential citation
• Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition

  2015cites this paper
• Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer.

  2014cites this paper
• The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.

  2014cites this paper
• Adaptive protein and phosphoprotein networks which promote therapeutic sensitivity or acquired resistance.

  2014cites this paper
• Clinical significance of epithelial-mesenchymal transition

  2014cites this paper
• Inhibitors EMT-Associated Kinase Switch That Induces Resistance to EGFR MIG 6 Pathway Orchestrates the − miR 200 − β The TGF

  2014cites this paper
• The Double-Edged Sword: Conserved Functions of Extracellular Hsp90 in Wound Healing and Cancer

  2014cites this paper
• Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors.

  2014cites this paper
• EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.

  2014cites this paper
• A review of the profile of endothelin axis in cancer and its management.

  2014cites this paper
• Ligand associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3 dependent cancer cells

  2014cites this paper
• Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.

  2014cites this paper
• Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling.

  2014cites this paper
• MICROFLUIDIC DEVICES AS IN-VITRO MICROENVIRONMENTS FOR STEM CELL CULTURE

  2014cites this paper
• Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives

  2014cites this paper
• Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition

  2014cites this paper
• EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer

  2014cites this paper
• Down-Regulation of 5-HT1B and 5-HT1D Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells

  2014cites this paper
• Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion

  2014cites this paper
• Genome-wide activities of RNA binding proteins that regulate cellular changes in the epithelial to mesenchymal transition (EMT).

  2014cites this paper
• Epithelial to mesenchymal transition in head and neck squamous cell carcinoma

  2014cites this paper
• Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis

  2014cites this paper
• Fhit Regulates EMT Targets through an EGFR/Src/ERK/Slug Signaling Axis in Human Bronchial Cells

  2014cites this paper
• Correction: Down-Regulation of 5-HT1B and 5-HT1D Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells

  2014cites this paper